{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:26:18Z","timestamp":1761164778705,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejpn.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T02:32:41Z","timestamp":1677983561000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution"],"prefix":"10.1016","volume":"43","author":[{"given":"Daniela","family":"Angelova-Toshkina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-1373","authenticated-orcid":false,"given":"Josua A.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-031X","authenticated-orcid":false,"given":"Thomas","family":"Traunwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Holzapfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Bette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Vollert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Bison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-1036","authenticated-orcid":false,"given":"Thomas","family":"Kr\u00f6ncke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria C.","family":"Bramswig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-6887","authenticated-orcid":false,"given":"Astrid K.","family":"Gnekow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Fr\u00fchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-0503","authenticated-orcid":false,"given":"Michaela","family":"Kuhlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2023.02.006_bib1","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejpn.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0037-1620239","article-title":"Phenotype-genotype correlation in children with neurofibromatosis type 1","volume":"49","author":"Barrea","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2023.02.006_bib3","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of health consensus development conference","volume":"45","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med. : official journal of the American College of Medical Genetics"},{"key":"10.1016\/j.ejpn.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nrl.2019.05.003","article-title":"Neurological manifestations of neurofibromatosis type 1: our experience","volume":"37","author":"Sanchez Marco","year":"2021","journal-title":"Neurologia"},{"key":"10.1016\/j.ejpn.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpeds.2010.10.001","article-title":"Mental, motor, and language development of toddlers with neurofibromatosis type 1","volume":"158","author":"Lorenzo","year":"2011","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9493837","article-title":"Attention deficit predicts intellectual functioning in children with neurofibromatosis type 1","volume":"2019","author":"Heimgartner","year":"2019","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dmcn.12734","article-title":"Cognition in children with neurofibromatosis type 1: data from a population-based study","volume":"57","author":"Lehtonen","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/dmcn.13526","article-title":"Neurodevelopmental disorders in children with neurofibromatosis type 1","volume":"59","author":"Vogel","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s13023-021-02051-5","article-title":"Executive functions and quality of life in children with neurofibromatosis type 1","volume":"16","author":"Roy","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","article-title":"Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the international NF1-ASD consortium team (INFact)","volume":"73","author":"Morris","year":"2016","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","article-title":"Natural history and management of low-grade glioma in NF-1 children","volume":"100","author":"Hernaiz Driever","year":"2010","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-021-02276-5","article-title":"Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)","volume":"141","author":"Fisher","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1212\/WNL.0000000000009458","article-title":"Nonoptic pathway tumors in children with neurofibromatosis type 1","volume":"95","author":"Mahdi","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","article-title":"A\u00a0multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1","volume":"88","author":"Mahdi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","article-title":"Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation","volume":"21","author":"Koczkowska","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejpn.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jps.2600800307","article-title":"Effect of glutathione depletion on the in\u00a0vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin","volume":"80","author":"Svensson","year":"1991","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.ejpn.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1469-8749.2011.04139.x","article-title":"Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning","volume":"54","author":"Piscitelli","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/87565640903265137","article-title":"Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood","volume":"34","author":"Chabernaud","year":"2009","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ejpn.2018.04.016","article-title":"Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: preliminary results","volume":"22","author":"Parmeggiani","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib23","first-page":"vdaa094","article-title":"Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies","volume":"2","author":"Traunwieser","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ejpn.2023.02.006_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1259\/bjr\/65246351","article-title":"Radiological classification of optic pathway gliomas: experience of a modified functional classification system","volume":"81","author":"Taylor","year":"2008","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib25","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1002\/hbm.24750","article-title":"Automated brain extraction of multisequence MRI using artificial neural networks","volume":"40","author":"Isensee","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ejpn.2023.02.006_bib26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.gim.2022.05.013","article-title":"Neurofibromatosis type 1: a comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75 children and adolescents","volume":"24","author":"Angelova-Toshkina","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","article-title":"Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1","volume":"64","author":"Rosser","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0883073812441059","article-title":"Cerebral vasculopathy in children with neurofibromatosis type 1","volume":"28","author":"Ghosh","year":"2013","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib29","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1542\/peds.2009-0152","article-title":"Cerebral arteriopathy in children with neurofibromatosis type 1","volume":"124","author":"Rea","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2023.02.006_bib30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.2007.136457","article-title":"Cerebrovascular dysplasia in neurofibromatosis type 1","volume":"79","author":"Cairns","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2023.02.006_bib31","first-page":"609","article-title":"Proton beam radiation-induced glioblastoma multiforme","volume":"63","author":"Schutt","year":"2019","journal-title":"J.\u00a0Neurosurg. Sci."},{"key":"10.1016\/j.ejpn.2023.02.006_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/01.wnl.0000257095.33125.48","article-title":"Moyamoya following cranial irradiation for primary brain tumors in children","volume":"68","author":"Ullrich","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0883073811423974","article-title":"Developmental delays in children with neurofibromatosis type 1","volume":"27","author":"Soucy","year":"2012","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PEP.0b013e3181f9dbc8","article-title":"Motor proficiency in children with neurofibromatosis type 1","volume":"22","author":"Johnson","year":"2010","journal-title":"Pediatr. Phys. Ther."},{"key":"10.1016\/j.ejpn.2023.02.006_bib35","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2023.02.006_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/dmcn.12038","article-title":"Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1","volume":"55","author":"Walsh","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/14737175.2014.953931","article-title":"Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions","volume":"14","author":"Schwetye","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejpn.2023.02.006_bib38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jpeds.2008.08.045","article-title":"Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior","volume":"154","author":"Krab","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/088307380201700811","article-title":"Cognitive deficits in neurofibromatosis 1","volume":"17","author":"North","year":"2002","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/0883073809350723","article-title":"Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1","volume":"25","author":"Pride","year":"2010","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/neuonc\/noq178","article-title":"Survival and long-term health and cognitive outcomes after low-grade glioma","volume":"13","author":"Armstrong","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A\u00a0mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejpn.2023.02.006_bib44","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1469-8749.2012.04377.x","article-title":"The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1","volume":"54","author":"Lidzba","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.eplepsyres.2013.02.021","article-title":"Epilepsy surgery in neurofibromatosis type 1","volume":"105","author":"Barba","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejpn.2023.02.006_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","article-title":"Seizures in neurofibromatosis 1","volume":"19","author":"Kulkantrakorn","year":"1998","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib47","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","article-title":"Epilepsy in NF1: a systematic review of the literature","volume":"36","author":"Bernardo","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejpn.2023.02.006_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jocn.2016.10.048","article-title":"Hippocampal sclerosis and associated focal cortical dysplasia-related epilepsy in neurofibromatosis type I","volume":"37","author":"Gales","year":"2017","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.ejpn.2023.02.006_bib49","article-title":"Neuroprotective effect of uncaria rhynchophylla in kainic acid-induced epileptic seizures by modulating hippocampal mossy fiber sprouting, neuron survival, astrocyte proliferation, and S100B expression","volume":"2012","author":"Liu","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejpn.2023.02.006_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","article-title":"Epilepsy in neurofibromatosis type 1","volume":"73","author":"Pecoraro","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejpn.2023.02.006_bib51","first-page":"177","article-title":"Comparison of 1H NMR chemical shifts of bovine and human insulins","volume":"4","author":"Craik","year":"1991","journal-title":"Pept. Res."},{"key":"10.1016\/j.ejpn.2023.02.006_bib52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajmg.a.36338","article-title":"Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study","volume":"164A","author":"Payne","year":"2014","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejpn.2023.02.006_bib53","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1651-2227.2010.01923.x","article-title":"Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1","volume":"99","author":"Feldmann","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib54","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.46.6.1660","article-title":"Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis","volume":"46","author":"Moore","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1037\/neu0000151","article-title":"Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: are T2-weighted hyperintensities related to executive dysfunction?","volume":"29","author":"Roy","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ejpn.2023.02.006_bib56","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/dmcn.14144","article-title":"Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging","volume":"61","author":"Eby","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.15274\/NRJ-2014-10055","article-title":"Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1","volume":"27","author":"Ertan","year":"2014","journal-title":"NeuroRadiol. J."},{"key":"10.1016\/j.ejpn.2023.02.006_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/a-1471-5897","article-title":"Doubling recruitment of pediatric low-grade glioma within two decades does not change outcome - report from the German LGG studies","volume":"233","author":"Gnekow","year":"2021","journal-title":"Klin. P\u00e4diatr."},{"key":"10.1016\/j.ejpn.2023.02.006_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.886697","article-title":"Optic pathway glioma in children with neurofibromatosis type 1: a multidisciplinary entity, posing dilemmas in diagnosis and management multidisciplinary management of optic pathway glioma in children with neurofibromatosis type 1","volume":"9","author":"Lohkamp","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.ejpn.2023.02.006_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/neuonc\/noaa153","article-title":"NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat","volume":"23","author":"Azizi","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/CPJ.0000000000000494","article-title":"Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1","volume":"8","author":"Griffith","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.ejpn.2023.02.006_bib62","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1158\/1078-0432.CCR-17-0589","article-title":"Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1","volume":"23","author":"Evans","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpn.2023.02.006_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111790","article-title":"Optic pathway glioma in type 1 neurofibromatosis: review of its pathogenesis, diagnostic assessment, and treatment recommendations","volume":"11","author":"Cassina","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejpn.2023.02.006_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpn.2015.12.002","article-title":"Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort","volume":"20","author":"Blanchard","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.02.006_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejpn.2023.02.006_bib67","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","article-title":"Genotype-phenotype correlations in neurofibromatosis and their potential clinical use","volume":"97","author":"Bettegowda","year":"2021","journal-title":"Neurology"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:40:38Z","timestamp":1761072038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379823000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":67,"alternative-id":["S1090379823000302"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.02.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"type":"print","value":"1090-3798"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}